Regenerative Medicine.
Precision Biologics.
Physician-Led Care.

UC-MSCs (umbilical cord mesenchymal stem cells) are allogeneic cells derived from the Wharton’s jelly of donated umbilical cord tissue, collected after healthy full-term births. They are biologically young, immune-privileged, and characterized by their capacity for immunomodulation and paracrine signaling — meaning they work primarily by releasing molecules that regulate inflammation and support tissue repair, rather than by replacing damaged cells directly. UC-MSCs have an extensive safety profile across thousands of clinical applications worldwide.

Exosomes are nanoscale extracellular vesicles (30–150 nanometers) released by stem cells. They carry concentrated molecular signals — proteins, growth factors, and genetic material — that influence how neighboring cells behave. Because they are acellular (not living cells), they do not replicate and carry a lower immunological risk profile. At OmniStem, exosomes are derived from UC-MSCs and used to deliver targeted regenerative signals via intravenous infusion, nebulization, or localized application.

PRP (Platelet-Rich Plasma) and PRGF (Plasma Rich in Growth Factors) are autologous biologics — meaning they are derived from the patient’s own blood. A small blood draw is processed to concentrate platelets and growth factors, which are then injected into targeted areas to support localized tissue repair. At OmniStem, PRP/PRGF is used as a complementary therapy alongside cellular protocols, particularly for joint, spine, hair, and aesthetic applications.

In the U.S., stem cell therapies are FDA-approved mainly for blood and immune disorders, particularly bone marrow transplantation. Current regulations do not allow the expanded use of allogeneic mesenchymal stem cells for other conditions. For this reason, some patients seek treatment in countries where different regulatory frameworks permit broader applications. 

At present, UC-MSC and exosome treatments are considered investigational and are not typically covered by most insurance plans. 

Our main clinic is in Punta Cana, Dominican Republic. We also maintain a presence in Pereira, Colombia. 

Most conventional medical practices focus on symptom management through medication or surgical intervention. Regenerative medicine takes a different approach by targeting the underlying biological mechanisms — inflammation, immune dysregulation, and impaired cellular signaling — that contribute to chronic conditions. OmniStem’s protocols are not a replacement for conventional care. They are designed to complement existing treatment plans under physician oversight. We encourage patients to maintain their relationship with their primary care providers throughout the process.